Search
Tolfenamic acid Action Pathway
smpdb.ca/view/SMP0126549Drug actionThe inhibition of both COX-1 and COX-2 by tolfenamic acid reduces the formation of prostaglandin H2 and therefore, prostaglandin E2 (PGE2). … The low concentration of prostaglandin E2 attenuates the effect it has on stimulating immune cells and pain fibers, consequently reducing inflammation and pain.
Acetohydroxamic acid Drug Metabolism
smpdb.ca/view/SMP0130492MetabolicAcetohydroxamic acid passes through the liver and is then excreted from the body mainly through the kidney. … Acetohydroxamic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Acetohydroxamic acidAcetic acid Drug Metabolism
smpdb.ca/view/SMP0130504MetabolicAcetic acid passes through the liver and is then excreted from the body mainly through the kidney. … Acetic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Acetic acidEtidronic acid Drug Metabolism
smpdb.ca/view/SMP0130677MetabolicEtidronic acid passes through the liver and is then excreted from the body mainly through the kidney. … Etidronic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Etidronic acidMedronic acid Drug Metabolism
smpdb.ca/view/SMP0130690MetabolicMedronic acid passes through the liver and is then excreted from the body mainly through the kidney. … Medronic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Medronic acidAlendronic acid Drug Metabolism
smpdb.ca/view/SMP0130694MetabolicAlendronic acid passes through the liver and is then excreted from the body mainly through the kidney. … Alendronic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Alendronic acidEthacrynic Acid Action Pathway
smpdb.ca/view/SMP0000097Drug actionEtacrynic acid (also known as ethacrynic acid and Edecrin) is a loop diuretic that can inhibit water reabsorption by binding and inhibiting solute carrier family 12 member 1 (also known as sodium-potassium-chloride … Binding of the transporter can prevent import of sodium from lumen from loop of Henle to basolateral interstitium, which lead to more hypertonic environment in lumen than interstitium, and result in prevention
Enzymes: Neutral and basic amino acid transport protein rBAT, Sodium- and chloride-dependent transporter XTRP3Mefenamic Acid Action Pathway
smpdb.ca/view/SMP0000109Drug actionMefenamic acid can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. … Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway.
Drugs: Glutamic acid · Glutathione · Mefenamic acid · Dinoprostone · Calcium · Magnesium cation +5 moreAminocaproic Acid Action Pathway
smpdb.ca/view/SMP0000286Drug actionAminocaproic acid, brand name Amicar, is a derivate of lysine and is an antifibrinolytic drug. Antifibrinolytics drugs are commonly used during major surgery to prevent significant blood loss. … This blockade inhibits plasminogen binding to fibrin and the conversion of plasminogen to plasmin. These prevents fibrin degradation and maintains the stability of fibrin clots.
Valproic Acid Metabolism Pathway
smpdb.ca/view/SMP0000635Drug metabolismValproic acid (VPA) is metabolized almost entirely in the liver, via at least there routes: glucuronidation, beta oxidation in the mitochondria, and cytochrome P450 mediated oxidation. … The key CYP-mediated reaction of the VPA metabolic pathway is the generation of 4-ene-VPA by CYP2C9, CYP2A6 and CYP2B6. These three enzymes also catalyze the formation of 4-OH-VPA and 5-OH-VPA.